NYSE:XPEV - US98422D1054 - ADR
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 60.29B | 40.87B | 30.68B | 26.86B | 20.99B | |||
Cost Of Goods | 50.80B | 33.94B | 29.09B | 23.61B | 18.17B | |||
Gross Profit | 9.49B | 6.93B | 1.59B | 3.24B | 2.82B | |||
Operating Expenses | 14.80B | 12.74B | 11.37B | 11.79B | 9.20B | |||
Research and Development | N/A | 6.46B | 5.28B | 5.21B | 4.11B | |||
Selling, General, and Administrative Expenses | 8.02B | 6.87B | 6.56B | 6.69B | 5.30B | |||
Operating Income | -5.30B | -5.81B | -9.78B | -8.55B | -6.38B | |||
Interest Income/Expense | N/A | 953.25M | 483.13M | -449.00M | 1.36B | |||
Other Income/Expense | 524.44M | 108.00M | 42.00M | 36.00M | 384.00M | |||
Non Recurring Items | N/A | -1.08B | -1.14B | -156.00M | -197.00M | |||
Income Before Taxes | -4.30B | -5.83B | -10.39B | -9.12B | -4.84B | |||
Income Tax | -38.40M | -70.00M | 37.00M | 25.00M | 26.00M | |||
Net Income | -4.28B | -5.79B | -10.38B | -9.14B | -4.86B | |||
EBITDA | N/A | -3.29B | -7.72B | -7.52B | -5.77B | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -5.35 | -6.75 | -11.91 | -10.67 | -5.91 | |||
Non GAAP EPS | -4.50 | -6.11 | -11.96 | -10.49 | -5.44 | |||
Statistics | ||||||||
Gross Profit Margin | 15.74% | 16.95% | 5.18% | 12.08% | 13.44% | |||
Profit Margin | -7.10% | -14.17% | -33.82% | -34.03% | -23.17% | |||
Operating Profit Margin | -8.80% | -14.22% | -31.89% | -31.84% | -30.41% |
All data in CNY